Applying a conceptual model for examining health-related quality of life in long-term breast cancer survivors: CALGB study 79804

Psycho-Oncology

Volumn 17, Issue 11, 2008, Pages 1108-1120

  Paskett, Electra D ^a,j   Herndon II, James E ^b,j   Day, Jeannette M ^b   Stark, Nancy N ^c,j   Winer, Eric P ^d,j   Grubbs, Stephen S ^e   Pavy, Michael D ^f   Shapiro, Charles L ^a   List, Marcy A ^g,j   Hensley, Martee L ^h,j   Naughton, Michelle A ^c   Kornblith, Alice B ^d,j   Habin, Karleen R ^i,j   Fleming, Gini F ^g   Bittoni, Marisa A ^a   Weeks, J C ^j   Dowell, J ^j  

^a OHIO STATE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d DANA FARBER CANCER INSTITUTE   (United States)

^e HELEN F GRAHAM CANCER CENTER   (United States)

^f Southeast Cancer Control Consortium Inc   (United States)

^g University of Chicago   (United States)

^h MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^j 1st Biennial Cancer Survivorship Conference ^*  (United States)

more..

Author keywords

Breast cancer survivor; Cancer; Health behaviors; Oncology; Quality of life

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ESTROGEN; FLUOROURACIL; RALOXIFENE; TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVOR; COMORBIDITY; CONCEPTUAL FRAMEWORK; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; EATING HABIT; ECONOMIC ASPECT; EXERCISE; FEMALE; FOLLOW UP; HEART DISEASE; HOT FLUSH; HUMAN; LIFESTYLE MODIFICATION; LOW DRUG DOSE; LYMPHEDEMA; MAJOR CLINICAL STUDY; MASTECTOMY; MENOPAUSAL SYNDROME; POSTMENOPAUSE OSTEOPOROSIS; PREDICTION; QUALITY OF LIFE; RELIGION; SMOKING; SMOKING CESSATION; SOCIAL PSYCHOLOGY; SOCIAL SUPPORT; VAGINAL DRYNESS;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CLIMACTERIC; COMBINED MODALITY THERAPY; COMORBIDITY; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; MIDDLE AGED; NEOPLASM STAGING; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SICK ROLE; SOCIAL SUPPORT; SOCIOECONOMIC FACTORS; SPIRITUALITY; SURVIVORS;

EID: 57649174189     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.1329     Document Type: Article

References (62)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2006. C A Cancer J Clin 2006;56:106-130.
2. Nasseri K. Secular trends in the incidence of female breast cancer in the United States, 1973-1998. Breast J 2004;10:129-135.
3. Casso D, Buist DS, Taplin S. Quality of life of 5-10 year breast cancer survivors diagnosed between age 40 and 49. Health Qual Life Outcomes 2004;2:25.
4. Dorval M, Maunsell E, Deschenes L, Brisson J, Masse B. Long-term quality of life after breast cancer: comparison of 8-year survivors with population controls. J Clin Oncol 1998;16:487-494.
5. Ganz PA, Desmond KA, Leedham B, Rowland JH, Meyerowitz BE, Belin TR. Quality of life in long-term disease-free survivors of breast cancer: a follow-up study. J Natl Cancer Inst 2002;94:39-49.
6. Kornblith AR, Herndon JE, Weiss RB et al. Long-term adjustment of survivors of early stage breast carcinoma 20 years, after adjuvant chemotherapy. Cancer 2003; 98:679-689.
7. Bower JE, Ganz PA, Desmond KA et al. Fatigue in long-term breast carcinoma survivors: a longitudinal investigation. Cancer 2006; 106:751-758.
8. Dow KH, Ferrell BR, Leigh S, Ly J, Gulasekaram P. An evaluation of the quality of life among long-term survivors of breast cancer. Breast Cancer Res Treat 1996;39:261-273.
9. Polinsky ML. Functional status of long-term breast cancer survivors: demonstrating chronicity. Health Soc Work 1994;19:165-173.
10. Schultz PN, Klein MJ, Beck ML, Stava C, Sellin RV. Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors. J Clin Nursing 2005;14:204-211.
11. Ferrell BR, Dow KH, Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res 1995;4:523-531.
12. Wood WC, Budman DR, Korzun AH et al. Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma. N Engl J Med 1994; 330:1253-1259.
13. Budman D, Berry DA, Cirrincione CT et al. Dose and dose intensity as determinants of outcome in the adjuvant treatment of breast cancer. J Natl Cancer Inst 1998;90:1205-1211.
14. Dow KH, Ferrell BR, Haberman MR, Eaton L. The meaning of quality of life in cancer survivorship. Oncol Nurs Forum 1999;26:519-528.
15. Ersek M, Ferrell BR, Dow KH, Melancon CH. Quality of life in women with ovarian cancer. West J Nurs Res 1997;19:334-350.
16. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. New England Medical Center, The Health Institute: Boston, MA, 1993.
17. Stewart AL, Ware J. Measure of Functioning and Well-being: The Medical Outcomes Study Approach. Duke University Press: Durham, NC, 1992.
18. Paskett E. Lymphedema: knowledge, treatment and impact among breast cancer survivors. Breast J 1999; 6:373-378.
19. George LK, Fillenbaum G. OARS methodology: a decade of experience in geriatric assessment. J Am Geriatrics Soc 1985;33:607-615.
20. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med 1991;32:705-714.
21. Anderson D, Bilodeau B, Deshaies G, Gilbert M, Jobin J. French-Canadian validation of the MOS Social Support Survey. Can J Cardiol 2005; 21:867-873.
22. Watts RJ. Sexual functioning, health beliefs and compliance with high blood pressure medications. Nurs Res 1982;31:278-283.
23. Wilcox S, Aragaki A, Mouton CP, Evenson KR, Wassertheil-Smoller S, Loevenger BL. The effects of widowhood on physical and mental health, health behaviors, and health outcomes: the Women's Health Initiative. Health Psychol 2003;22:513-522.
24. Holmes TH, Rahe RH. The Social Readjustment Rating Scale. J Psychosom Res 1967;11:213-218.
25. Andersen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med 1994;10: 77-84.
26. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1:385-401.
27. Kash KM, Jacobsen PB, Holland JC, Osborne MP, Miller DG. Measuring breast cancer anxiety. Proceedings of the 42nd Annual Meeting of the Academy of Psychosomatic Medicine, Palm Springs, CA, November 1995; 13.
28. Lerman C, Daly M, Sands C et al. Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 1993;85: 1074-1080.
29. McNair DM, Lorr M, Droppleman LF. EITS Manual for the Profile of Mood States. Educational and Testing Service: San Diego, CA, 1971.
30. Spielberger CD, Gorsuch RL, Lushene RD. Manual for the State-trait Anxiety Inventory. Consulting Psychologists Press: Palo Alto, CA, 1970.
31. Taylor JA. A personality scale of manifest anxiety. J Abnorm Psychol 1953;48:285-290.
32. Polivy J. Psychological effects of mastectomy on a woman's feminine self-concept. J Nerv Ment Dis 1977;164:77-87.
33. Bauer SM, Hseih SF, Hseih CC et al. Treatment-related menopause in female cancer survivors: prevalence and quality of life issues [Abstract 102]. Proceedings of the 26th Annual Oncology Nursing Society Congress (San Diego, CA, May 2001) in Oncology Nursing Forum, 2001; 28:339.
34. Holland JC, Kash KM, Passik S et al. A brief spiritual beliefs inventory for use in quality of life research in life-threatening illnesses. Psycho-Oncology 1998;7:460-469.
35. Holland JC, Herndon J, Kornblith AB et al. A sociodemographic data collection model for cooperative clinical trials. Proc Am Soc Cancer Oncol 1992;445:157.
36. Greenberg DB, Kornblith AB, Herndon JE et al. Quality of life of adult leukemia survivors treated on clinical trials of the Cancer and Leukemia Group B from 1971-1988: predictors for later psychological distress. Cancer 1997;80:1936-1944.
37. Kornblith AB, Anderson J, Cella DF et al. Hodgkin's disease survivors at increased risk for problems in psychosocial adaptation. Cancer 1992;70:2214-2224.
38. Cantril H. The Patterns of Human Concerns. Rutgers University Press: New Brunswick, NJ, 1965.
39. Cohen J. Statistical Power Analysis for the Behavioral Sciences (2nd edn). Ehrlbaum: Hillsdale, NJ, 1988.
40. Hosmer DW, Lemeshow S. Applied Logistic Regression. Wiley: New York, 2000.
41. Trunzo J, Pinto B. Social support as a mediator of optimism and distress in breast cancer survivors. J Consult Clin Psychol 2003; 71:805-811.
42. Stava CJ, Lopez A, Vassilopoulou-Sellin R. Health profiles of younger and older breast cancer survivors. Cancer 2006; 107:1752-1759.
43. Kornblith AB, Herndon JE, Zuckerman E et al. Social support as a buffer to the psychological impact of stressful life events in women with breast cancer. Cancer 2001;91:443-454.
44. Clough-Gorr K, Ganz P, Silliman RA. Older breast cancer survivors: factors associated with change in emotional well-being. J Clin Oncol 2007;25: 1334-1340.
45. Shapiro CL, Recht A. Side effects of adjuvant treatment of breast cancer. New Engl J Med 2001;344:1997-2008.
46. Bower JE, Ganz PA, Desmond K, Rowland JH, Myerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 2000;18.
47. Cella D, Davis K, Breitbart W, Curt G. The Fatigue Coalition. Cancer-related fatigue: prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. J Clin Oncol 2001; 19: 3385-3391.
48. Broeckel JA, Thors CL, Jacobsen PB, Small M, Cox CE. Sexual functioning in long-term breast cancer survivors treated with adjuvant chemotherapy. Breast Cancer Res Treat 2002;75:241-248.
49. Ressel GW. NIH releases statement on managing pain, depression, and fatigue in cancer. Am Fam Physician 2003;67:423-424.
50. Coleman RE. Hormone- and chemotherapy-induced bone loss in breast cancer. Oncology (Williston Park) 2004;8:16-20.
51. Rugo HS. Strategies for the prevention of treatment-related bone loss in women receiving adjuvant hormonal therapy. Clin Breast Cancer 2007;7 (Suppl 1):S21-S28.
52. Nelson RL, Turyk M, Kim J, Persky V. Bone mineral density and the subsequent risk of cancer in the NHANES I follow-up cohort. BMC Cancer 2002;2:22.
53. Kanis JA, McCloskey EV, Powles T, Paterson AHG, Ashley S, Spector T. A high incidence of vertebral fracture in women with breast cancer. Br J Cancer 1999;79:1179-1181.
54. Hillner BE, Ingle JN, Chlebowski RT, Gralow J, Yee GC, Janjan NA. American Society of Clinical Oncology 2003 update on the role of biphosphonates and bone health issues in women with breast cancer. J Clin Oncol 2003;21:4042-4057.
55. Kornblith AB, Ligibel J. Psychosocial and sexual functioning of survivors of breast cancer. Review. Semin Oncol 2003; 30:799-813.
56. Deimling GT, Bowman KF, Sterns S, Wagner LJ, Kahana B. Cancer-related health worries and psychological distress among older adult, long-term cancer survivors. Psycho-Oncology 2006;15: 306-320.
57. Stewart DE, Cheng AM, Duff S et al. Attributions of cause and recurrence in long-term breast cancer survivors. Psycho-Oncology 2001;10:179-183.
58. Kendall AR, Mahue-Giangreco M, Carpenter CL, Ganz PA, Bernstein L. Influence of exercise activity on quality of life in long-term breast cancer survivors. Qual Life Res 2005;14:361-371.
59. Biglia N, Cozzarella M, Cacciari F et al. Menopause after breast cancer: a survey on breast cancer survivors. Maturitas 2003; 45:29-38.
60. Greendale GA, Petersen L, Zibecchi L, Ganz PA. Factors related to sexual function in postmenopausal women with a history of breast cancer. Menopause 2001; 8:111-119.
61. Crandall C, Peterson L, Ganz PA, Greendale GA. Association of breast cancer and its therapy with menopause related symptoms. Menopause 2004;11: 519-530.
62. Carpenter JS, Elam JL, Ridner SH, Carney PH, Cherry GJ, Cucullu HL. Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol Nurs Forum 2004;31:591-598.